The melatonergic pathway and its interactions in modulating respiratory system disorders.

Area of Science:

• Neuroimmunology
• Endocrinology
• Pulmonology

Background:

• Melatonin is an intracellular regulator influencing neuroendocrine, antioxidant, and mitochondrial functions.
• It plays a role in sleep-wake cycles, aging, and immune system optimization.
• Melatonin and its agonists are explored for treating diverse medical disorders.

Purpose of the Study:

• To review the role of melatonin in respiratory system function under normal and pathological conditions.
• To explore melatonin's potential clinical utility in various lung diseases.

Main Methods:

• Literature review focusing on melatonin's mechanisms in lung tissue.
• Analysis of melatonin's interaction with signaling molecules, oxidant status, and immune responses.
• Examination of melatonin's integration with alpha 7 nicotinic and aryl hydrocarbon receptors.

Main Results:

• Melatonin normalizes damaged lung tissues through mechanisms like regulating signaling molecules and oxidant status.
• It optimizes mitochondrial function and resets immune responses within the circadian rhythm.
• Melatonin influences lipid raft function and cellular processes crucial for lung health.

Conclusions:

• Melatonin demonstrates potential therapeutic value for bronchial asthma, COPD, lung cancer, and infections.
• Its role in optimizing mitochondrial function, particularly with specific receptors, offers a framework for understanding pulmonary disorders.
• Melatonin's multifaceted actions suggest broad applicability in respiratory medicine.